BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26504149)

  • 1. Long-Term Prognostic Risk in Lower Extremity Peripheral Arterial Disease as a Function of the Number of Peripheral Arterial Lesions.
    Smolderen KG; van Zitteren M; Jones PG; Spertus JA; Heyligers JM; Nooren MJ; Vriens PW; Denollet J
    J Am Heart Assoc; 2015 Oct; 4(10):e001823. PubMed ID: 26504149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-reactive protein and brain natriuretic peptide as predictors of adverse events after lower extremity endovascular revascularization.
    Stone PA; Schlarb H; Campbell JE; Williams D; Thompson SN; John M; Campbell JR; AbuRahma AF
    J Vasc Surg; 2014 Sep; 60(3):652-60. PubMed ID: 24795153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crural Index and extensive atherosclerosis of crural vessels are associated with long-term cardiovascular mortality in patients with symptomatic peripheral artery disease.
    Wickström JE; Jalkanen JM; Venermo M; Hakovirta HH
    Atherosclerosis; 2017 Sep; 264():44-50. PubMed ID: 28763728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic polyvascular disease and the risks of cardiovascular events and all-cause death.
    Zhang Q; Wang A; Zhang S; Li N; Chen S; Zhang Y; Zhou Y; Wu S; Zhao X
    Atherosclerosis; 2017 Jul; 262():1-7. PubMed ID: 28463782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality in patients with premature lower extremity atherosclerosis.
    Rana H; Andrews JS; Chacko BG; Hansen KJ; Levy PJ
    J Vasc Surg; 2013 Jan; 57(1):28-35; discussion 35-6. PubMed ID: 23146425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease.
    Urbonaviciene G; Martin-Ventura JL; Lindholt JS; Urbonavicius S; Moreno JA; Egido J; Blanco-Colio LM
    Atherosclerosis; 2011 Dec; 219(2):892-9. PubMed ID: 21962403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B; Kragsterman B; Falkenberg M; Hasvold P; Johansson S; Thuresson M; Nordanstig J
    J Vasc Surg; 2016 Oct; 64(4):1009-1017.e3. PubMed ID: 27209402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anatomic runoff score predicts cardiovascular outcomes in patients with lower extremity peripheral artery disease undergoing revascularization.
    Jones WS; Patel MR; Tsai TT; Go AS; Gupta R; Hedayati N; Ho PM; Jazaeri O; Rehring TF; Rogers RK; Shetterly SM; Wagner NM; Magid DJ
    Am Heart J; 2015 Aug; 170(2):400-8. PubMed ID: 26299239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting long-term prognosis in stable peripheral artery disease with baseline functional capacity estimated by the Duke Activity Status Index.
    Senthong V; Wu Y; Hazen SL; Tang WH
    Am Heart J; 2017 Feb; 184():17-25. PubMed ID: 27892883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported symptoms on questionnaires and anatomic lesions on duplex ultrasound examinations in patients with peripheral arterial disease.
    van Zitteren M; Vriens PW; Heyligers JM; Burger DH; Nooren MJ; de Fijter WM; Denollet J; Smolderen KG
    J Vasc Surg; 2012 Apr; 55(4):1025-1034.e2. PubMed ID: 22244858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A; Kozak M; Sabovic M; Božic M; Stegnar M; Poredoš P; Kravos A; Barbic-Žagar B; Pohar Perme M; Stare J;
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality rates at 10 years are higher in diabetic than in non-diabetic patients with chronic lower extremity peripheral arterial disease.
    Mueller T; Hinterreiter F; Poelz W; Haltmayer M; Dieplinger B
    Vasc Med; 2016 Oct; 21(5):445-452. PubMed ID: 27067137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced high-density lipoprotein cholesterol: A valuable, independent prognostic marker in peripheral arterial disease.
    Martinez-Aguilar E; Orbe J; Fernández-Montero A; Fernández-Alonso S; Rodríguez JA; Fernández-Alonso L; Páramo JA; Roncal C
    J Vasc Surg; 2017 Nov; 66(5):1527-1533.e1. PubMed ID: 28666822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of incidental renal artery stenosis on long-term mortality in patients with peripheral arterial disease undergoing vascular procedure.
    Mui KW; Zeebregts CJ; van den Hout H; van Baal JG; Navis G; Jan-Woittiez A
    J Vasc Surg; 2011 Sep; 54(3):785-90. PubMed ID: 21798691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
    Subherwal S; Bhatt DL; Li S; Wang TY; Thomas L; Alexander KP; Patel MR; Ohman EM; Gibler WB; Peterson ED; Roe MT
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):541-9. PubMed ID: 22715460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study.
    Subherwal S; Patel MR; Kober L; Peterson ED; Bhatt DL; Gislason GH; Olsen AM; Jones WS; Torp-Pedersen C; Fosbol EL
    Eur J Prev Cardiol; 2015 Mar; 22(3):317-25. PubMed ID: 24398369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal Artery Stenosis in Patients with Peripheral Artery Disease: Prevalence, Risk Factors and Long-term Prognosis.
    Aboyans V; Desormais I; Magne J; Morange G; Mohty D; Lacroix P
    Eur J Vasc Endovasc Surg; 2017 Mar; 53(3):380-385. PubMed ID: 27919610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.
    Soden PA; Zettervall SL; Ultee KH; Landon BE; O'Malley AJ; Goodney PP; DeMartino RR; Arya S; Schermerhorn ML;
    J Vasc Surg; 2016 Dec; 64(6):1633-1644.e1. PubMed ID: 27575814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of adjunct femoral endarterectomy in lower extremity bypass on perioperative and 1-year outcomes.
    Soden PA; Zettervall SL; Shean KE; Deery SE; Kalish JA; Healey CT; Kansal N; Schermerhorn ML;
    J Vasc Surg; 2017 Mar; 65(3):711-719.e1. PubMed ID: 27633166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of invasive treatment in lower extremity peripheral arterial disease.
    van Zitteren M; Vriens PW; Burger DH; de Fijter WM; Gerritsen GP; Heyligers JM; Nooren MJ; Smolderen KG
    J Vasc Surg; 2014 Feb; 59(2):400-408.e2. PubMed ID: 24461863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.